News

Combination therapy — pairing androgen deprivation therapy (ADT) with FDA-approved oral agents — has become a widely used ...
During the Addressing Cardiovascular Risk and Intervening Early webinar, experts discuss innovative strategies for cardiovascular disease prevention, emphasizing risk assessment, lifestyle changes, ...
A new study reveals that some men who are diagnosed with "Grade Group one" (GG1) prostate cancer may actually be at higher ...
Prostate cancer affects many American men. Misinformation can delay diagnosis and treatment. Regular screening is important, ...
Jyong Biotech targets urinary disorders with a novel botanical pipeline, but clinical and liquidity risks temper near-term ...
The global statistics are terrifying. Prostate cancer is the fourth most common cancer in all populations, the second most ...
Most people think of vaccines as being "preventive," and taken to "prevent or lessen the impact of certain infectious diseases," David Braun, a professor of medicine and member of the Center of ...
With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent ...
Results of a study led by VHIO’s Prostate Cancer Group suggest that treatment with CDK4/6 inhibitors followed by senloytic ...
Cardiac biomarkers may not only be indicative of cardiac events, but could also be predictive of future cancer diagnosis, ...
Cite this: Finasteride as a Chemopreventive Agent in Prostate Cancer: Impact of the Prostate Cancer Prevention Trial on Urologic Practice - Medscape - Aug 01, 2006.
Prostate cancer (PCa) represents a significant public health challenge in Germany, with increasing incidence and economic impact. This study assessed the cost-effectiveness of 10 screening strategies: ...